Study seeks rapid, paper-based test to detect cancer cells in cerebrospinal fluid

With time being of the essence for patients facing one of cancer’s most dire complications, UCLA researchers are working to create a new test to detect cancer’s spread to the central nervous system on the same day as the doctor’s visit.

Physical health has its yardsticks. Mental health is still searching for the right ruler

A national initiative led by the National Institutes for Mental Health is now underway to find figurative “rulers” that can accurately measure and compare the quality of the various mental health treatments available.

UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy

UCLA has received a $120 million commitment from Dr. Gary Michelson and his wife, Alya, to kick-start the California Institute for Immunology and Immunotherapy, an innovative public-private partnership aimed at spurring breakthrough discoveries that prevent and cure diseases and catalyze economic growth and innovation in Los Angeles.

Study reveals racial disparities in Huntington’s disease diagnoses

New research led by UCLA Health revealed that Black patients with Huntington’s disease in the U.S. and Canada received their diagnoses, on average, one year later compared to White patients after symptoms first appear.

Lali Medina-Kauwe, PhD, Named Associate Dean of Cedars-Sinai PhD Programs

Lali Medina-Kauwe, PhD, a nationally regarded expert in molecular engineering and nanoparticle cancer research, has been named associate dean of PhD programs and director of the PhD program in Biomedical and Translational Sciences at Cedars-Sinai.

Cedars-Sinai Names Vice Dean of Medical Education

Laurence Katznelson, MD, a national leader in graduate medical education and a distinguished physician-scientist in endocrinology and metabolism, will join Cedars-Sinai as vice dean of Medical Education on May 1.

Lali Medina-Kauwe, PhD, Named Inaugural Chair in Medical Discovery

Cedars-Sinai has named Lali Medina-Kauwe, PhD, as the inaugural holder of the Carol Moss Foundation Chair in Medical Discovery.

Human-Machine Interfaces Work Underwater, Generate Their Own Power

In Applied Physics Reviews, scientists at UCLA describe their development of a type of wearable human-machine interface device that is stretchable, inexpensive, and waterproof. The device is based on a soft magnetoelastic sensor array that converts mechanical pressure from the press of a finger into an electrical signal. The device involves two main components: a layer that translates mechanical movement to a magnetic response and a magnetic induction layer consisting of patterned liquid metal coils.

UCLA: Global Study Finds Critical Gaps in Workplace Protections

A sweeping study of 193 countries by the UCLA WORLD Policy Analysis Center reveals critical gaps in legal protections against discrimination on the job.
Nearly one in four countries continue to have no legal protection from discrimination at work based on race and ethnicity, according to the study, just published in the journal Equality, Diversity and Inclusion.

UCLA expert available to comment on proposed ‘‘Health and Economic Recovery Omnibus Emergency Solutions Act’’ (HEROES Act) focus on paid sick leave

Dr. Jody Heymann, founding director of the UCLA Fielding School of Public Health’s WORLD Policy Analysis Center and a UCLA distinguished professor of public health, public policy, and medicine, is available as an expert on the proposed ‘‘Health and Economic Recovery Omnibus…

UCLA Fielding School of Public Health experts available for media inquiries related to COVID-19

The UCLA Fielding School of Public Health has multiple experts available for media inquiries related to COVID-19. These include experts with English, Chinese (Mandarin), French, German, and Spanish fluency. They include: Professor Hiram Beltrán-Sánchez Hiram Beltrán-Sánchez is an associate professor of…

UCLA Fielding School of Public Health faculty experts available for media covering novel coronavirus (COVID-19)

UCLA Fielding School of Public Health experts available for media covering novel coronavirus (COVID-19) include: Dr. Robert J. Kim-Farley serves as professor-in-residence of epidemiology and community health sciences at the Fielding School. His previous roles include director of the Division of…

Botanical drug is shown to help patients with head and neck cancers

In a UCLA-led phase I clinical trial, a new plant-based drug called APG-157 showed signs of helping patients fight oral and oropharyngeal cancers. These cancers are located in the head and the neck.
APG-157 is made up of multiple compounds produced by plants, including curcumin. UCLA Jonsson Comprehensive Cancer Center researchers found that treatment with this botanical drug resulted in high concentrations of curcumin and its byproducts circulating in the blood and absorbed by tumor tissues within three hours after being taken orally.